Why should biotherapeutic developers and manufacturers rely on particle analyzers originally designed for marine water or aviation fuel?
The answer from Halo Labs is that you shouldn’t have to.
By looking at particle analysis with a biotherapeutic developer’s workflows, constraints, Critical Quality Attributes (CQA), and end goals in mind, Halo Labs has created innovative technology designed specifically for life science studies.
Aura® particle analyzers are driving decision making during late discovery and throughout development, parts of the process where conventional particle analyzer technology is too cumbersome and sample-consuming to use.
They are also ensuring drug safety during the manufacturing process, through USP 788 compendial measurement methods.
With the Aura family of particle analyzers, the team at Halo Labs is succeeding at our goal of overcoming challenges in biotherapeutic development and enabling biotherapeutic scientists to develop faster, smarter, and safer medicines.
What Drives Us
As scientists and engineers, our mission is to empower drug developers in the biopharma industry with innovative particle analysis technology, designed specifically for their workflows, to enhance therapeutic development and manufacturing processes.
By delivering novel, made-for-purpose technologies, we aim to provide breakthrough scientific insights, reduce development time and improve patient safety, advancing the biopharma industry towards a brighter future.
Innovate with purpose
We focus our innovation on making significant advances that enhance and accelerate the workflows of drug developers and manufacturers, so you can make the safe and effective therapeutics we need to build a healthier future.
Listen to succeed
We believe that innovation is a journey that we undertake together with you, our customer. To help you achieve your goals faster and better, we need to listen to your feedback and deliver the advances you need.
Execute with integrity
Because your measurements are only as reliable as the instruments you use, we recognize that it is our responsibility to ensure we provide the highest quality instruments, consumables, service, and support.
Achieve more together
Within Halo Labs, we bring together multiple disciplines and diverse viewpoints so we can see existing workflows from new angles and deliver true innovation.
Our venture support comes from Agilent Technologies, Research Corporation Technologies (RCT), BioAdvance, Broad Oak Capital Partners, and Ben Franklin Technology Partners.
News & Events
Biologics Manufacturing Korea
Songdo Convensia Convention Center, South KoreaJune 14, 2023 - June 15, 2023